Hongyuan Gao

ORCID: 0000-0001-9068-2364 · 7 papers in corpus · active 2010-2025

Study types

  • article 5
  • other 1
  • rct 1

Condition tags

  • endometriosis 7
  • mesh:D004715 3
  • infertility 2
  • endometrioma 1
article 2025
·doi:10.1016/j.rbmo.2025.105220
other 2025
Reproductive health ·doi:10.1186/s12978-025-01977-4
article 2023
Scientific reports ·doi:10.1038/s41598-023-32797-w

This study aimed to investigate the metabolite profile and inflammatory state of follicular fluid (FF) in women with stage III-IV ovarian endometriosis (OE) who underwent in vitro fertilization (IVF). A cohort of 20 consecutive patients wit…

rct 2022
Reproductive health ·doi:10.1186/s12978-022-01500-z

BACKGROUND: This study aimed to investigate the medroxyprogesterone acetate (MPA) + HMG protocol vs ultra-long gonadotrophin releasing hormone (GnRH) agonist protocol in patients with advanced ovarian endometriosis who received in vitro fer…

article 2020
Frontiers in endocrinology ·doi:10.3389/fendo.2020.00129

Methods: 450 infertile patients with severe endometriosis undergoing IVF/ICSI were randomized to: medroxyprogesterone acetate +hMG; dydrogesterone+hMG; and progesterone +hMG. Ovulation was induced with a gonadotropin-releasing hormone agoni…

article 2020
Annals of translational medicine ·doi:10.21037/atm.2020.02.15

BACKGROUND: This study investigated the effects of medroxyprogesterone acetate (MPA) on the oocytes and embryos in patients with advanced endometriosis who had a normal ovarian reserve and tubal infertility and received controlled ovarian h…

article 2010
·doi:10.1093/humrep/de.25.s1.242

Introduction: Endometriosis, defined as the growth of endometrial tissue outside \nthe uterine cavity is a common gynaecological disorder affecting 10-15% \nof women in their reproductive years. It is a major clinical problem causing in- \n…